Synthesis and evaluation of prop-2-yn-1-yl 4,6-di-O-acetyl-2,3-dideoxy-a-D-erythro-hex-2-enopyranoside against non-albicans species of Candida, and effectiveness of amphotericin B or ketoconazole combination/Síntese e avaliação do prop-2-in-1-il 4,6-di-O-acetil-2,3-didesoxi-a-D-eritro-hex-2-enopiranosídeo contra espécies não albicans de Candida e resultados da associação com a anfotericina B ou com o cetoconazol

Soares, Gustavo Lima; Santos, Cosme Silva; Freitas, Juliano Carlo Rufino de; Oliveira, Wylly Araújo de.
Rev Pan-Amaz Saude ; 9(2): 43-50, 2018. tab., form
Artigo em Português | Instituto Evandro Chagas (SOPHIA) | ID: iec-17535

Documentos relacionados

  1. A Second-Generation Fungerp Analog, SCY-247, Shows Potent <i>In Vitro</i> Activity against Candida auris and Other Clinically Relevant Fungal Isolates.
  2. <i>Candida auris</i> Genetics and Emergence.
  3. <i>In vitro</i> activity of manogepix and comparators against infrequently encountered yeast and mold isolates from the SENTRY Surveillance Program (2017-2022).
  4. <i>Candida auris</i>-macrophage cellular interactions and transcriptional response.
  5. Ketoconazole/calix[n]arenes-based compounds improve the antifungal activity against azole-resistant Candida isolates.
  6. Liposomal formulation of a new antifungal hybrid compound provides protection against <i>Candida auris</i> in the <i>ex vivo</i> skin colonization model.
  7. Exploring therapeutic avenues: mesenchymal stem/stromal cells and exosomes in confronting enigmatic biofilm-producing fungi.
  8. <i>In vitro</i> activity of ibrexafungerp against clinically relevant echinocandin-resistant <i>Candida</i> strains.
  9. The Impact of Cultivation Media on the In Vitro Biofilm Biomass Production of Candida spp.
  10. Investigation of the Physiological, Biochemical and Antifungal Susceptibility Properties of Candida auris.